Faleck Herbert J 4
4 · Edge Therapeutics, Inc. · Filed Jun 20, 2018
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+119,667→ 119,667 totalExercise: $1.10→ Common Stock (119,667 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.